title: Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy.
authors: Tineke
authors: T
authors: van de Weijer
authors: Bas
authors: B
authors: Havekes
authors: Lena
authors: L
authors: Bilet
authors: Joris
authors: J
authors: Hoeks
authors: Lauren
authors: L
authors: Sparks
authors: Madeleen
authors: M
authors: Bosma
authors: Sabina
authors: S
authors: Paglialunga
authors: Johanna
authors: J
authors: Jorgensen
authors: Mirian C H
authors: MC
authors: Janssen
authors: Gert
authors: G
authors: Schaart
authors: Hans
authors: H
authors: Sauerwein
authors: Joep L
authors: JL
authors: Smeets
authors: Joachim
authors: J
authors: Wildberger
authors: Rudolf
authors: R
authors: Zechner
authors: Vera B
authors: VB
authors: Schrauwen-Hinderling
authors: Matthijs K C
authors: MK
authors: Hesselink
authors: Patrick
authors: P
authors: Schrauwen
mesh_terms: D000328:Adult; D000483:Alleles; D001629:Bezafibrate / Q000494:pharmacology / Q000627:therapeutic use*; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008049:Lipase / Q000235:genetics*; D050356:Lipid Metabolism / Q000187:drug effects; D008052:Lipid Metabolism, Inborn Errors / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism; D009135:Muscular Diseases / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D016896:Treatment Outcome; D000217:Acyltransferases
chemical_list: D001629:Bezafibrate; D005227:Fatty Acids; D000960:Hypolipidemic Agents; D008049:Lipase; C494794:PNPLA2 protein, human; D000217:Acyltransferases